Literature DB >> 15304094

Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin.

Márta Széll1, Zsuzsanna Bata-Csörgo, Andrea Koreck, Andor Pivarcsi, Hilda Polyánka, Csilla Szeg, Magdolna Gaál, Attila Dobozy, Lajos Kemény.   

Abstract

The extra domain A of fibronectin (EDA+ oncofetal isoform of fibronectin was recently reported to be overexpressed in psoriatic uninvolved epidermis. It has been proposed that the abnormal presence of EDA+ oncofetal protein at the dermal-epidermal junction in the uninvolved skin may provide the "psoriatic" environment in which keratinocytes are in a preactivated state with regard to mitogenic signals (e.g., T cell lymphokines). To determine the possible sources of cellular fibronectin in the non-lesional psoriatic skin, we aimed to investigate whether keratinocytes could produce the EDA+ oncofetal form of fibronectin. RT-PCR studies revealed that both cultured normal keratinocytes and HaCaT cells express the EDA+ splice variant of fibronectin mRNA, and in HaCaT cells the EDA+/EDA- transcript ratio was elevated compared with normal keratinocytes. Cultured keratinocytes and HaCaT cells showed intracytoplasmic staining with an EDA+ fibronectin-specific antibody and among the positively stained cells many showed mitosis. Using RT-PCR, western blot analysis, and flow cytometry, we showed that in synchronized HaCaT cells the amount of both total fibronectin and its EDA+ isoform change with the proliferation/differentiation state of HaCaT cells and peak in highly proliferating cells. We show that in short-term ex vivo cultures, a small population of EDA+ fibronectin containing cell population appear among psoriatic uninvolved, but not normal epidermal cells. We also demonstrate that cell attachment has a strong influence on the expression of both total and EDA+ fibronectin. Our results suggest that proliferating keratinocytes could be the sources of the psoriasis susceptibility-related EDA+ oncofetal fibronectin in the epidermis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304094     DOI: 10.1111/j.0022-202X.2004.23224.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

Review 1.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

2.  The use of an in vitro 3D melanoma model to predict in vivo plasmid transfection using electroporation.

Authors:  Bernadette Marrero; Richard Heller
Journal:  Biomaterials       Date:  2012-01-13       Impact factor: 12.479

3.  Splicing factors differentially expressed in psoriasis alter mRNA maturation of disease-associated EDA+ fibronectin.

Authors:  E Szlavicz; K Szabo; G Groma; Z Bata-Csorgo; F Pagani; L Kemeny; M Szell
Journal:  Mol Cell Biochem       Date:  2017-06-06       Impact factor: 3.396

Review 4.  Transcriptional Basis of Psoriasis from Large Scale Gene Expression Studies: The Importance of Moving towards a Precision Medicine Approach.

Authors:  Vidya S Krishnan; Sulev Kõks
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

Review 5.  DAMPening inflammation by modulating TLR signalling.

Authors:  A M Piccinini; K S Midwood
Journal:  Mediators Inflamm       Date:  2010-07-13       Impact factor: 4.711

6.  In vitro dedifferentiation of melanocytes from adult epidermis.

Authors:  Bernadett Kormos; Nóra Belso; Attila Bebes; Gábor Szabad; Sarolta Bacsa; Márta Széll; Lajos Kemény; Zsuzsanna Bata-Csörgo
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

7.  Psoriasis-Associated Inflammatory Conditions Induce IL-23 mRNA Expression in Normal Human Epidermal Keratinocytes.

Authors:  Evelyn Kelemen; Éva Ádám; Stella Márta Sági; Anikó Göblös; Lajos Kemény; Zsuzsanna Bata-Csörgő; Márta Széll; Judit Danis
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

8.  Expression and functional studies on the noncoding RNA, PRINS.

Authors:  Krisztina Szegedi; Anikó Göblös; Sarolta Bacsa; Mária Antal; István Balázs Németh; Zsuzsanna Bata-Csörgő; Lajos Kemény; Attila Dobozy; Márta Széll
Journal:  Int J Mol Sci       Date:  2012-12-21       Impact factor: 5.923

Review 9.  PRINS, a primate-specific long non-coding RNA, plays a role in the keratinocyte stress response and psoriasis pathogenesis.

Authors:  Márta Széll; Judit Danis; Zsuzsanna Bata-Csörgő; Lajos Kemény
Journal:  Pflugers Arch       Date:  2016-03-03       Impact factor: 3.657

10.  Stress-Related Regulation Is Abnormal in the Psoriatic Uninvolved Skin.

Authors:  Renáta Bozó; Judit Danis; Lili Borbála Flink; Dániel László Vidács; Lajos Kemény; Zsuzsanna Bata-Csörgő
Journal:  Life (Basel)       Date:  2021-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.